Cisplatin-resistant A549 non-small cell lung cancer cells can be identified by increased mitochondrial mass and are sensitive to pemetrexed treatment.

Gao, Yanyun; Dorn, Patrick; Liu, Shengchen; Deng, Haibin; Hall, Sean R R; Peng, Ren-Wang; Schmid, Ralph A; Marti, Thomas M

Gao, Yanyun; Dorn, Patrick; Liu, Shengchen; Deng, Haibin; Hall, Sean R R; Peng, Ren-Wang; Schmid, Ralph A; Marti, Thomas M.

Afiliação

Gao Y; 1Department of General Thoracic Surgery, Inselspital, Bern University Hospital, Murtenstrasse 50, 3008 Bern, Switzerland.
Dorn P; 2Department of BioMedical Research, University of Bern, Bern, Switzerland.
Liu S; 1Department of General Thoracic Surgery, Inselspital, Bern University Hospital, Murtenstrasse 50, 3008 Bern, Switzerland.
Deng H; 2Department of BioMedical Research, University of Bern, Bern, Switzerland.
Hall SRR; 2Department of BioMedical Research, University of Bern, Bern, Switzerland.
Peng RW; 3Department of Intensive Care Medicine, Inselspital, Bern University Hospital, Bern, Switzerland.
Schmid RA; 1Department of General Thoracic Surgery, Inselspital, Bern University Hospital, Murtenstrasse 50, 3008 Bern, Switzerland.
Marti TM; 2Department of BioMedical Research, University of Bern, Bern, Switzerland.

Cancer Cell Int ; 19: 317, 2019.

Article em En | MEDLINE | ID: mdl-31798346

Palavras-chave

Chemotherapy; Cisplatin; Lung cancer; Mitochondrial activity; Mitochondrial mass; NSCLC; Pemetrexed; Resistance

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies Idioma: En Revista: Cancer Cell Int Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Suíça País de publicação: Reino Unido

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google